Relay Therapeutics: Peers

The FY2025 (Dec) proxy of Relay Therapeutics names 22 peer companies for pay. Among Relay Therapeutics and these peers, CEO pay was 11th highest of 13 and total shareholder return was 9th highest of 12.

11th highest of 13in Relay Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$2.8M$27.8M

9th highest of 12in Relay Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:

$14$414

Pay peer group, FY2025 (Dec) proxy

Cogent Biosciences
BridgeBio Pharma
Arcus Biosciences
Kymera Therapeutics
Vir Biotechnology
CRISPR Therapeutics AG
Arvinas
Beam Therapeutics
Intellia Therapeutics
Denali Therapeutics
Schrodinger
Tango TherapeuticsNot disclosed
Alector, Inc.Not disclosedNot disclosed
Allogene Therapeutics, Inc.Not disclosedNot disclosed
Editas Medicine, Inc.Not disclosedNot disclosed
ErascaNot disclosedNot disclosed
IGM Biosciences, Inc.Not disclosedNot disclosed
Iovance BiotherapeuticsNot disclosedNot disclosed
Recursion PharmaceuticalsNot disclosedNot disclosed
Sana BiotechnologyNot disclosedNot disclosed
SpringWorks Therapeutics, Inc.Not disclosedNot disclosed
Zentalis Pharmaceuticals, Inc.Not disclosedNot disclosed
22 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.